Attaining a sustained virological response following antiviral therapy for hepatitis C was associated with a lower risk of death from liver-related or cardiovascular causes, according to findings published in the Journal of Viral Hepatitis. Even among people with advanced liver disease, direct-acting antiviral therapy for hepatitis C virus (HCV) has a high cure rate, but successful treatment may not fully reverse existing liver damage. Further, SVR was linked to a lower risk of liver-related death as well as cardiovascular mortality, irrespective of cirrhosis status. Click here to read the study abstract in the Journal of Viral Hepatitis. Click here to learn more about hepatitis C.
At Wellness Axis we want to encourage habits of wellness, Increase awareness of factors and resources contributing to well-being, Inspire and empower individuals to take responsibility for their own health, and to support a sense of community. Wellness can be thought of as the quality or state of being in good health.